News for Regulus Therapeutics Inc. (RGLS)

PR NewswireSAN DIEGO, March 4, 2025 SAN DIEGO, March 4, 2025 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused

NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. ( OVID), a biopharmaceutical company dedicated to developing small-molecule medicines for

We recently published a list of 10 Cheapest Stocks Insiders Are Buying Recently. In this article, we are going to take a look at where Regulus Therapeutics Inc.

Colorado-based Aclarion, Inc. (ACON) is up over 30 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Colorado-based Aclarion, Inc. (ACON) is up over 30 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

On January 30, 2025, David Baltimore, a Director at Regulus Therapeutics Inc (RGLS), purchased 19,610 shares of the company. Following this transaction, the ins

On January 30, 2025, Joseph Hagan, the Chief Executive Officer of Regulus Therapeutics Inc, purchased 50,000 shares of the company. Following this transaction,

Regulus Therapeutics (RGLS) shares tumbled 24% after the company reported results from a study analysis for its ADPKD program and issued a regulatory update. Read more here.

PR NewswireSAN DIEGO, Nov. 26, 2024 SAN DIEGO, Nov. 26, 2024 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused

Regulus Therapeutics secures exclusive license for kidney disease treatment

Regulus Therapeutics reports Q2 2024 financial results, misses EPS by $0.02.

Rising awareness of benefits of RNA-based therapeutics and vaccines among healthcare providers and regulatory bodies propelling their production, says...

Regulus Therapeutics shares target raised, rated Buy on positive study results

Jones Trading maintains Buy on Regulus with $8 target

Document UNITED STATES SECURITIES...

April 5, 2024 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today's roundup of stocks to watch i...

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

REDWOOD CITY, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...